Log in to save to my catalogue

MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants...

MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2306255855

MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition

About this item

Full title

MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition

Publisher

United States: Public Library of Science

Journal title

PLoS biology, 2019-09, Vol.17 (9), p.e3000354-e3000354

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

The nucleotide-binding-domain (NBD)-and leucine-rich repeat (LRR)-containing (NLR) family, pyrin-domain-containing 3 (NLRP3) inflammasome drives pathological inflammation in a suite of autoimmune, metabolic, malignant, and neurodegenerative diseases. Additionally, NLRP3 gain-of-function point mutations cause systemic periodic fever syndromes that a...

Alternative Titles

Full title

MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2306255855

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2306255855

Other Identifiers

ISSN

1545-7885,1544-9173

E-ISSN

1545-7885

DOI

10.1371/journal.pbio.3000354

How to access this item